Area of research
Reproductive Medicine · Molecular Biology
Research interest
Research interests include Ovarian cancer diagnosis and treatment, Cancer-related molecular mechanisms research, RNA modifications and cancer, and RNA Research and Splicing.
Tumour extracellular vesicle surface Protein-mRNA integration assay for early detection of epithelial ovarian cancer
Pro-endometriosis macrophage release of IL-33 is key for endometriosis pain and lesion formation
Large-scale genome-wide association study of 398,238 women unveils seven novel loci associated with high-grade serous epithelial ovarian cancer risk
Rare germline genetic variation in PAX8 transcription factor binding sites and susceptibility to epithelial ovarian cancer
Single-cell transcriptomic analysis of endometriosis
<scp>α‐Ketoglutarate</scp>–Dependent <scp>KDM6</scp> Histone Demethylases and <scp>Interferon‐Stimulated</scp> Gene Expression in Lupus
The tumor multi-omic landscape of endometrial cancers developed on a germline genetic background of adiposity
Molecular Subclasses of Clear Cell Ovarian Carcinoma and Their Impact on Disease Behavior and Outcomes
A multi-level investigation of the genetic relationship between endometriosis and ovarian cancer histotypes
The transcription factor PAX8 promotes angiogenesis in ovarian cancer through interaction with SOX17
DNA methylation and transcriptomic features are preserved throughout disease recurrence and chemoresistance in high grade serous ovarian cancers
Reprogramming of the FOXA1 cistrome in treatment-emergent neuroendocrine prostate cancer
Predicting master transcription factors from pan-cancer expression data
Pleiotropy-guided transcriptome imputation from normal and tumor tissues identifies candidate susceptibility genes for breast and ovarian cancer
A multi-level investigation of the genetic relationship between endometriosis and ovarian cancer histotypes
Pleiotropy-guided transcriptome imputation from normal and tumor tissues identifies candidate susceptibility genes for breast and ovarian cancer.
Prostate cancer reactivates developmental epigenomic programs during metastatic progression
Combining genome-wide studies of breast, prostate, ovarian and endometrial cancers maps cross-cancer susceptibility loci and identifies new genetic associations
Pleiotropy-guided transcriptome imputation from normal and tumor tissues identifies new candidate susceptibility genes for breast and ovarian cancer
A transcriptome-wide association study of high-grade serous epithelial ovarian cancer identifies new susceptibility genes and splice variants
A Study of High-Grade Serous Ovarian Cancer Origins Implicates the SOX18 Transcription Factor in Tumor Development
Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women
Identification of novel epithelial ovarian cancer loci in women of African ancestry
Genetics and Epigenetics of Infertility and Treatments on Outcomes
Functional Analysis and Fine Mapping of the 9p22.2 Ovarian Cancer Susceptibility Locus
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer
Inherited variation in circadian rhythm genes and risks of prostate cancer and three other cancer sites in combined cancer consortia
Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci
Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types
A COL11A1-correlated pan-cancer gene signature of activated fibroblasts for the prioritization of therapeutic targets